| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26acde46369081547d4007d976afa0e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f1dc5b578dad8d3491a37b9da138f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4749c886dfae9f3098e56b4f0656b825 |
| publicationDate |
2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2385276-A1 |
| titleOfInvention |
COMPOUNDS FOR THE TREATMENT OF ALZHEIMER. |
| abstract |
Compounds for the treatment of Alzheimer's. # PDKI inhibitor compounds can be used for the treatment of diseases associated with the formation of amyloid deposits, among which is Alzheimer's disease. PDKI activation levels in a cell treated with an amyloid protein can be used to identify compounds capable of inhibiting cell death induced by amyloid deposits potentially useful in the treatment of diseases associated with the formation of amyloid deposits. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8697685-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011275611-A1 |
| priorityDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |